Cape Town-based biotech consortium Afrigen is working on a messenger RNA Covid-19 vaccine in an attempt to make up for vaccine shortages on the continent.
The jab is based on the Moderna formula.
The company says it has the backing of the World Health Organisation and the Covax scheme.
Two years into vaccination, barely 5% of those eligible for it across Africa have been able to get a jab.
If you come across Covid-19 vaccination information that you do not trust, read Covid-19 vaccine myths debunked: Get the facts here. If you can’t find the facts you’re looking for, email us at the address mentioned in the article and we will verify the information with medical professionals.
We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can
trust. For only R75 per month, you have access to
a world of in-depth analyses, investigative journalism,
top opinions and a range of features. Journalism
strengthens democracy. Invest in the future today.